Recent News

• 09.08.2025 - BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration
• 07.28.2025 - BullFrog AI to Present at BTIG Annual Virtual Biotechnology Conference
• 07.22.2025 - Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development
• 07.18.2025 - Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on July 23
• 07.17.2025 - BullFrog AI Launches bfPREP, a New AI-Powered Data Preparation Module in Its BullFrog Data Networks Solutions Library
• 07.10.2025 - BullFrog AI Unveils BullFrog Data Networks™ Solutions Library, Expanding Scalable AI-Powered Biomedical Insight Platform to Large Enterprises
• 06.20.2025 - BullFrog AI’s Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar
• 06.12.2025 - BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients

Recent Filings

• 08.27.2025 - 8-K Current report
• 08.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.08.2025 - DEF 14A Other definitive proxy statements
• 07.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.03.2025 - 4 Statement of changes in beneficial ownership of securities